Faculty Scholarship
2019

Recruitment Effort and Costs from a Multi-center Randomized
Controlled Trial for Treating Depression in Type 2 Diabetes
Barbara A. Myers
Yegan Pillay
W. Guyton Hornsby Jr.
Jay Shubrook
Chandan Saha

See next page for additional authors

Follow this and additional works at: https://researchrepository.wvu.edu/faculty_publications

Authors
Barbara A. Myers, Yegan Pillay, W. Guyton Hornsby Jr., Jay Shubrook, Chandan Saha, Kieren J. Mather,
Karen Fitzpatrick, and Mary de Groot

Myers et al. Trials
(2019) 20:621
https://doi.org/10.1186/s13063-019-3712-x

RESEARCH

Open Access

Recruitment effort and costs from a multicenter randomized controlled trial for
treating depression in type 2 diabetes
Barbara A. Myers1, Yegan Pillay2, W. Guyton Hornsby Jr3, Jay Shubrook4, Chandan Saha1, Kieren J. Mather1,
Karen Fitzpatrick3 and Mary de Groot1*

Abstract
Background: Participant recruitment for clinical trials is a significant challenge for the scientific research community.
Federal funding agencies have made continuation of funding of clinical trials contingent on meeting recruitment
targets. It is incumbent on investigators to carefully set study recruitment timelines and resource needs to meet those
goals as required under current funding mechanisms. This paper highlights the cost, labor, and barriers to recruitment
for Program ACTVE II, a successful multisite randomized controlled trial of behavioral treatments for depression in
adults with type 2 diabetes, conducted in rural and urban settings in three states.
Methods: Quantitative and qualitative data on recruitment were gathered from study staff throughout the study
recruitment period and were used to calculate costs and effort. The study utilized two main approaches to recruitment:
(1) relying on potential participants to see ads in the community and call a toll-free number; and (2) direct phone calls
to potential participants by study staff.
Results: Contact was attempted with 18,925 people to obtain the enrolled sample of 140. The cost of recruitment
activities during the 4.5-year recruitment period totaled $190,056, an average cost of $1358 per enrolled participant.
Qualitative evaluations identified multiple barriers to recruitment.
Conclusions: Recruitment for Program ACTIVE II exemplifies the magnitude of resources needed to reach recruitment
targets in the current era. Continuous evaluation, flexibility, and adaptation are required on the part of investigators,
community partners, and funding agencies to successfully reach high-risk populations in rural and urban areas.
Trial registration: ClinicalTrials.gov, NCT03371940. Registered on 13 December 2017.
Keywords: Study recruitment, Diabetes, Depression, Clinical trial

Background
Randomized controlled trials (RCT) remain the gold
standard for evaluating the effectiveness of interventions
in healthcare research. Critical to the success of these
trials is recruitment of study participants in order to
have sufficient statistical power to detect the effects of
interventions [1]. Recruitment is increasingly challenging
for clinical trials across all domains of health research,
particularly for studies recruiting from the community.
Potential barriers include characteristics and stigma
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associated with the condition being studied, differences
in cultural expectations and experience with research
across study sites, and challenges engaging community
healthcare providers and systems. However, because
translational trials evaluate the effectiveness of interventions within the community [2], these studies are crucial
to evaluating the implementation of these interventions
in real-world contexts.
Mental health studies can be particularly challenging for
recruitment. For those with major depressive disorder
(MDD), withdrawal from regular activities is common. Eligible people may be less likely to engage and more difficult
to retain in clinical trials, even if leaving the house to attend study appointments is not required [3]. A review of
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recruitment to depression treatment trials offering cognitive behavioral therapy (CBT) by computer reported enrollment rates of 2%–60% and uptake rates (actually
participating in the treatment) of 3%–25%, representing
the wide range of variability in acceptance of and participation in depression treatment trials [4]. The stigma of
mental health conditions is an additional barrier for many
[5]. Participating in mental health studies requires both
acceptance of the condition and willingness to address it.
This may create a significant struggle for the participant if
shame or stigma are involved [6].
An individual’s culture, social background, and community also powerfully influence their perception of research and likelihood of participation [7, 8]. In many
rural, medically underserved areas, patients commonly
have a low opinion of the quality of their locally available
healthcare and limited direct experience with participation in clinical research [9]. Research teams seen as an
extension of this establishment may be viewed with
skepticism [10]. In this setting, investigators need to
build trust and perform recruitment activities simultaneously. This trust takes time to build and establish and
relies on relationships among researchers, patients, and
care providers. For example, the Appalachian region is
well-known for its overrepresentation of a number of
serious medical problems [11]. Despite the need, there
are significant misgivings of the medical system among
many people in this region [9]. This can lead to delays in
care and resistance to enrolling in trials [12, 13].
Multicenter trials necessarily deal with these cultural
values at each of the different study sites, with each
community having its own sets of values. Efforts to build
trust and creative solutions to study-related problems
that work in one area may not work in another. This
represents an added barrier to successfully recruiting
and demands even more effort and flexibility among
members of the research team.
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The purpose of this paper is to present a case study of
recruitment and retention for Program ACTIVE II, a
successful, NIDDK-funded behavioral health trial [14].
We present our recruitment strategy, barriers, and costs
associated with this trial.

Methods
Study design

Program ACTIVE II was a multisite RCT for adults with
type 2 diabetes and MDD [14]. The purpose of the study
was to test the comparative effectiveness of manualized
(i.e. conducting an intervention according to a manual)
exercise (EX) and cognitive behavioral (“talk”) therapies
(CBT) for the treatment of depression, individually or in
combination (EX+CBT), against usual care (UC). The
study protocol was approved by the Institutional Review
Boards at each of the individual sites (Indiana University
1105005684, 1308973934; Ohio University 11F031; West
Virginia University H-23246).
Potential study participants were identified using a
variety of methods, described below, from the communities surrounding the three participating study sites.
Research staff trained in the study protocol and approved by the local site Institutional Review Boards
(IRB) conducted all contacts with potential participants
to assess their interest and eligibility. During screening
calls, information was provided about the study using an
approved script. If interested, participants gave verbal consent to continue with eligibility screening. Self-reported
medical information was collected (see Table 1 for medical exclusion criteria). Those not excluded based on
medical information were then screened for psychiatric
eligibility. Potential participants who were eligible at medical and psychiatric screening by phone were invited to an
in-person baseline eligibility assessment (baseline) where
each potential participant provides written informed consent before completing any study-related activities. These

Table 1 Study exclusion criteria
Medical exclusions

Psychiatric exclusions

• Age 18 years or older
• Not able to walk
• Currently pregnant or planning on becoming pregnant in the next year
• History of diabetic ketoacidosis
• Continuous insulin therapy since type 2 diabetes diagnosis
• History of stroke or transient ischemic attack
• Recent cardiac event (diagnosed angina, PTCA, any cardiac intervention
for CAD or tachydysrhythmias in the past 6 months)
• Laser surgery for proliferative retinopathy in the past 6 months
• Aortic stenosis or other sever valvular heart disease or atrial fibrillation
• Lower limb amputation
• Asensory proliferative retinopathy
• Uncontrolled hypertension
• Current use of daytime oxygen (severe COPD)
• Class III or IV heart failure
• Diagnosis of type 2 diabetes < 1 year

• No diagnosis of current MDD
• Active suicidal ideation or history of suicide attempt
• Bipolar depression
• Evidence of psychotic symptoms or history of psychotic
disorder
• Current substance abuse or dependence
• Co-morbid anxiety or eating disorders where MDD is not
the primary presentation
• If on antidepressant medication, stable dose and usage for
at least 6 weeks
• Current therapy for MDD by a mental health professional

PTCA Percutaneous transluminal coronary angioplasty, CAD Coronary artery disease, MDD major depressive disorder, COPD chronic obstructive pulmonary disease
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baseline assessments were held at fitness centers within
the three areas where recruitment took place. Each person
then completed a psychiatric interview by phone. Following all baseline activities, an enrollment committee
formally evaluated baseline results to determine eligibility
and appropriateness for the study for each potential
participant. Those not eligible were referred to other
services. Eligible participants were randomized, notified of
their randomization group (EX, CBT, EX+CBT, or UC),
and assigned to an intervention provider, if relevant.
Details of the study design and eligibility criteria have
been detailed elsewhere [15].
Recruitment approach

Participants were recruited from rural southeastern Ohio
(OH), north-central West Virginia (WV), and central
Indiana (IN) communities. To ensure that recruitment
goals were met, the study utilized multiple recruitments
approaches, continually assessing the effectiveness of
each, and adjusting strategies as necessary [16]. We
classified recruitment identification strategies by who
made the initial contact. Initial contacts initiated by the
potential participant were classified as Inbound and
those the study team initiated as Outbound.
Inbound recruitment strategies

Inbound recruitment used a flexible, multifaceted approach,
involving outreach to physicians, health departments, libraries, grocery stores, pharmacies, advertisements in newspapers, and flyers posted in public areas. As recruitment
methods were implemented, each was reviewed for effectiveness, altering or expanding as necessary to meet recruitment goals.
The main initial recruitment strategy for the study was
via physician practices. This included providers affiliated
with the study and those seeing patients with diabetes
(e.g. endocrinologists, primary care providers, nurse
practitioners). Providers were presented study information and asked if contact with patients could occur (e.g.
letters to patients, in-office contact, phone calls to patients). Patients who received study information were
instructed to call the study team. This outreach was later
expanded to include pharmacists, diabetes educators,
and diabetes education classes. Study staff also attended
health fairs hosted by healthcare providers, community
organizations, social justice groups, employer-hosted
employee health fairs, and diabetes education groups,
providing information about diabetes and depression,
study promotional materials, and study flyers. Additional
flyers and posters were distributed throughout the communities at libraries, churches, community centers,
pharmacies, grocery stores, and to health departments to
distribute at diabetes classes.
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Advertisements were placed in local community newspapers. Limited advertising was also instituted on Facebook, targeting adult users with an interest in diabetes.
Further outreach occurred via radio public service announcements (at the OH site), television segments (OH
and WV), and radio segments (IN). These media spots
aired locally on public radio and television stations as
well as during local evening news broadcasts.
Additional outreach was conducted by direct mail or
email to fitness facility members (at the IN and OH
sites) and patient lists (WV and IN). Study emails were
also sent to registrants of the Indiana Clinical and
Translational Sciences Institute’s (CTSI) clinical trials
registry (INResearch.org). At the IN site, advertisements
were placed on the university’s electronic classifieds
board, accessible by students, staff, and faculty.
Outbound recruitment strategies

Electronic medical records from physician practices and
volunteer research registries were used to identify prospective participants, who were then directly contacted
by the study team. This strategy was utilized at the IN
and WV sites. WV conducted outreach to local physician offices. Interested practices allowed the study team
contact patients first by mail and then by phone. The IN
site partnered with ResNet, a service of the Indiana
CTSI, to access patient data in the Eskenazi and IU
Health systems. In addition, the IN site utilized the
Indiana CTSI’s INresearch.org participant registry. After
sending initial emails introducing the study, registrants
with type 2 diabetes were contacted by a research assistant. The Ohio University IRB did not approve Outbound
calling at the OH site. Unlike the other two sites, OH
did not have institutional agreements with healthcare
systems to share protected health information with researchers to facilitate Outbound outreach.
Analyses

All contacts with potential participants were logged at the
time of contact into a study database. Contact information
included the date, time, and nature of the contact. Logged
contacts included phone calls (such as study introduction
calls, screening, scheduling, psychiatric interviews, etc.),
mailings (such as appointment scheduling letters), and inperson appointments (such as eligibility assessments). In
addition to logging the contact, the time needed to
complete the contact was also recorded, allowing us to
track the effort spent on various recruitment tasks. These
records were reviewed to determine time spent on recruitment activities, broken down into phone screening and
baseline eligibility assessment contacts. Descriptive statistics were used to characterize count, cost, and proportions
of individuals in each outcome category. Qualitative data
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were collected from process notes recorded from team
meetings over the study period.

Results
Quantitative data
Individuals screened and enrolled

Figure 1 characterizes recruitment flow using Inbound
and Outbound strategies. A total of 18,925 potential
participants were attempted contact, representing all
patients on call lists for Outbound recruitment (n = 18,
067) plus individuals who responded Inbound to
community-based recruitment (n = 858) across the three
study sites. For Inbound callers, 143 screened eligible for
baseline while 464 were ineligible during phone screening. Of the 143 Inbound respondents who were referred
for baseline, 74 enrolled in the study.
For Outbound recruitment, 154 people were eligible
for baseline while 4220 were ineligible at phone screening. Another 6000 individuals declined participation and
7693 could not be reached for screening. Of the 154 respondents who were referred for baseline, 66 completed
the assessment and enrolled in the study. The enrollment rate across the population in which contact was
attempted was approximately 1% (140 enrolled divided
by 18,925 people total).
Differences in recruitment rates were observed between the Inbound and Outbound approaches (Fig. 1
and Table 2). Forty-three percent of individuals could
not be contacted from the Outbound calling list while
12% of Inbound respondents could not be re-contacted.
Of those who were reached, the rate of self-withdrawal
from consideration was three times higher in the Outbound approach compared with Inbound approach (58%
vs 20%). For those who were interested and completed

Fig. 1 Enrollment flow chart: Inbound vs Outbound
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phone screening, ineligibility was frequent in both
groups though notably higher in those contacted using
the Outbound call strategy (96% vs 76%). Although the
numbers of Outbound (n = 18,067) and Inbound (n =
858) pools of people vastly differed, similar numbers of
individuals screened eligible for baseline (Outbound =
154 versus Inbound =143). Of those who were reached
for phone screening, the success rate of ultimately enrolling the study participants was 15 times higher in the Inbound calling group compared with the Outbound
calling group (9.7% vs 0.6%).
Effort required to recruit and enroll participants

Recruitment efforts for the study began in May 2012 at
the WV and OH sites (see Fig. 2). Based on data collected
during the pilot study (R34DK71545) [17], we anticipated
that it would be feasible to recruit the entire sample from
the WV and OH sites. However, because recruitment
rates at these two sites were lower than expected, recruitment began at the IN site in December 2013 to expedite
enrollment. December 2013 also marked the start of Outbound calling at the WV site. As a result of these changes,
the recruitment rate rose from 5.4 participants per quarter
to 14.2 participants per quarter. This rate continued to
February 2015 when recruitment ceased at the OH site.
Because WV started recruitment without the use of Outbound calling, the enrollment rate there demonstrates the
effectiveness of the Outbound strategy by increasing the
average quarterly enrollment rate from 0.6 to 2.9 participants enrolled per quarter.
Several key developments during the recruitment
period are evident in Fig. 2. These included direct mailings by the OH and WV sites in February 2013, the initiation of Outbound recruitment strategies by the IN and
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Table 2 Screening and enrollment numbers and costs

WV sites in January 2014, cessation of recruitment efforts at the OH site in February 2015, and an increase in
incentives to participants to enhance recruitment and retention in February 2014 and July 2015.
In order to estimate staff effort needed to achieve recruitment goals, average times for each contact activity
were calculated. Group mean values were used to estimate for the missing entries. For all phone screening recruitment efforts, the estimated cumulative time spent
on these efforts was 3567 h, the majority of which was
consumed by Outbound calling (3209 h). An average of
25.5 h of personnel time was spent on all phone recruitment activities for each person enrolled (Table 2).
A total of 1397 h of staff time was spent on baseline
activities for the 297 people who screened eligible by
phone. This included time for scheduling assessments,
mailing letters, in-person assessment activities, and the
full psychiatric interview. Of the 297, 140 people completed baseline and were eligible for study participation.
The average time for eligibility assessments to reach 140
participants was 10 h per enrolled participant. Adding
the baseline time to the phone screening time, a total of
4964 h was required for all direct recruitment and enrollment efforts, an average of 35.5 h per participant enrolled, to obtain the final enrollment of 140 participants.

include both salary and benefits. The total calculation of
all eligibility screening activities was $117,093 (see Table
2). Outbound calls accounted for the majority of recruitment expenditures ($75,709) due to the time involved.
The remaining phone screening figure, $8435, was attributable to Inbound calls. Baseline activities added $32,
949 in expenditures. The average amount to screen and
enroll each participant into the study was $836.
Additional funds were used for advertising and outreach. Across all three sites, an estimated $72,963 was
spent on newspaper advertising, printing posters, and
postage for direct mailings. This figure is comparable to
the Outbound calling efforts. Total sum of all recruitment, screening, and enrollment activities was estimated
at $190,056, which represents an average of $1358 per
participant enrolled in the study.
Qualitative observations

The study team across all three sites met 1–2 times per
month throughout the funding period. During these
meetings, the study investigators discussed a variety of
barriers, giving context to the extraordinary effort required by the study teams to meet recruitment goals.
These barriers included geographic factors, institutional
factors, study personnel factors, and cultural and social
barriers, as we describe next.

Costs of participant recruitment

Staff labor and advertising costs were calculated to determine the total cost of recruitment per participant.
Staff labor rates were figured at $23.59 per hour to

Geographic factors

The differing geographical and cultural landscape at
each of the study sites provided opportunities and
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Fig. 2 Cumulative participant enrollment

challenges for recruitment. Physical distance and transportation infrastructure posed challenges to recruitment efforts at the rural OH and WV sites. The lack of
public transportation in rural communities presented a
unique problem to recruitment that could have been a
factor in motivation to participate in the study. Participants were not compensated for travel to and from assessment sites and some locations for assessments were
a fair distance from residences. Ohio and West Virginia
participants lived an average of 11 miles and 13.5 miles
from the closest assessment sites, respectively, which
were located in communities surrounding the study
sites in order to be closer to the population areas where
the participants lived. However, some participants at
these sites lived as far as 20–25 miles from the nearest
assessment site, for a round trip as much as 50 miles
away from the locations were the study procedure
would take place. This present a significant burden to
the participants, particularly those who were randomized to receive both CBT and exercise interventions, for
as many as two appointments per week during the
intervention period.

Institutional factors

The recruitment strategies were influenced by personnel
composition and the research climate within each university. Ohio recruitment took place at Ohio University,
which is predominantly a teaching institution. While
Ohio University has ties to many of the 29 Appalachian
counties in southern Ohio, the history and reach of
clinical trials have traditionally been on a smaller scale.
Formal collaborative partnership agreements with private practices and health systems in the surrounding
area did not exist before the start of the study and
needed to be established on an individual basis. A total
of five healthcare systems partnered with OH over the
course of the study. A request to the Ohio University
IRB to make Outbound calls to potential participants
was denied, limiting this site to the use of Inbound recruitment strategies.
West Virginia University has a long-standing history
of clinical research, with the majority being conducted
in the basic sciences and T1 translational trials. Institutional infrastructure leveraged for recruitment at this site
included partnership with the West Virginia University
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CTSI, collaborative research agreements between the
university and multiple healthcare systems serving
northern WV, and a large-scale electronic medical record system from which eligible patients could be identified for recruitment.
In Indiana, recruitment was conducted at the Indiana
University School of Medicine (IUSM), the lead study
site. IUSM along with the Indiana CTSI have longstanding collaborations with the Eskenazi Health and
Indiana University Health systems to collaborate on participant recruitment for clinical trials. These agreements,
in partnership with the Regenstrief Institute’s Data Core,
facilitated access to patient lists in order to conduct
Outbound recruitment by identifying potentially eligible
participants. Additional assistance was provided by the
Indiana CTSI Research Network (ResNet), whose research assistants performed the majority of Outbound
calling to medically screen interested patients and refer
eligible patients to the study team.
Institutional differences across the sites expanded or
limited the options available to investigators in reaching
potential participants. While all sites were influenced by
structural and regulatory changes in healthcare markets
and delivery that occurred during the study period from
2012 to 2016, each site entered this period of change
with different characteristics, resulting in more or less
dramatic changes during the study period. For example,
the communities around OH underwent a dramatic
transformation in the consolidation of many small
private primary care practices into larger healthcare organizations. Contractual contingencies on productivity
expectations of physicians in these organization placed
an implicit and, at times, an explicit limitation on physician efforts to convey study information to patients.
While business managers and physicians acknowledged
the benefits of how the study could complement their
work and the potential benefits for patients, they were
hindered by time and resource restrictions, which is
consistent with the finding of other researchers in rural
environments with limited resources [18].
Study personnel factors

The organization of the study teams contributed to relative strengths and challenges for each site. For example,
at WV, study staffing was initially provided by graduate
students. While this provided high-quality talent, the nature of the program limited the amount of time students
could serve as study employees. This staff turnover contributed to challenges associated with establishing relationships with community organizations. A full-time
project coordinator was hired in year 3, which facilitated
greater continuity in building relationships with community partners as well as planning and implementation of
new strategies. At OH, development of a new research
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center precipitated changes in study staffing, which ultimately precluded ongoing participation of OH in further enrollment.
Cultural and social barriers

Cultural barriers to recruitment included the burden of
living with MDD, limited prior experience with clinical
trials, and stigma associated with depression. Initial
Inbound recruitment approaches needed potential participants to be sufficiently motivated to call a toll-free
number. Since study inclusion criteria required the diagnosis for MDD, it is likely that some potential participants were unable to participate due to the manifest
symptoms of depression such as hopelessness, lack of
energy, anhedonia, and impaired social interactions. A
significant number (296 people, 34.5%) who made the
call to the toll-free number did not meet full criteria for
MDD, which supports the hypothesis that people with
higher burden of depression were less likely to contact
the study team. Recruitment strategies such as mailings
and fliers posted at clinics, doctor’s offices, churches,
and community centers have a lower response rate when
compared to recruitment strategies such as the use of a
professional interviewer to follow up a mailing or word
of mouth [19, 20].
The target communities at each study site differed in
levels of experience with clinical trials. Individuals living
in rural areas have limited exposure to clinical trials
compared to their urban counterparts, which appeared
to contribute to greater hesitancy to respond to Inbound
recruitment efforts. Perceptions of researchers as outsiders and the perception of participation in research as
being a “guinea pig” contributed to hesitancy to engage
in screening.
The benefits of participating in a RCT may have been
viewed with reluctance, especially given that participants
could not be promised tangible benefits other than what
they may receive by being randomly assigned to a treatment group. As a result, randomization to a specific
treatment group without choice may have dissuaded individuals from volunteering. People who are seeking
treatment for MDD frequently do not wish to be
assigned to a Usual Care group, risking the possibility of
receiving no treatment for the three months of the intervention period. This resulted in some eligible participants declining to participate in the study. Additionally,
the possibility of being assigned to a counseling group
may have influenced participation due to stigma associated with counseling.
At the IN site, clinical trials are more familiar to potential participants, but those trials typically involve fewer demands on participant time and engagement. Participants
employed in hourly positions working in service industries
consistently reported difficulty in knowing their work
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schedules far enough in advance to be able to keep study
appointments. As a result, adaptations were made to accommodate work schedules. In addition, the target participant population at this site had an expectation of payment
for study participation. A decision to institute and increase
participant incentives across all sites was made on the
basis of these public expectations.

Discussion
Community recruitment of participants is critical to the
advancement of all forms of science, particularly behavioral translational trials. Increasingly, clinical trials must
compete for participant attention, interest, and time
against a backdrop of considerable life demands and opportunities to easily obtain reliable health information.
Funders and investigators recognize the central role that
recruitment plays in the success of funded research.
Underestimation of the effort and costs needed for successful recruitment is a modifiable variable that investigators can and should address during the study planning
phase of the research. Here, the Program ACTIVE II
study [14] experience is shared as a case example of the
breadth and depth of recruitment strategies that were required to overcome barriers to study success as well as
the monetary costs incurred (Table 3).
Endemic to the Program ACTIVE II study design, we
encountered the following challenges: the specific eligibility criteria of the study (duration of type 2 diabetes
for at least one year while meeting full DSM-IV-TR
criteria for current MDD; medically appropriate for
community-based exercise) [21], requirements for study
participation (attending 2–3 appointments required for
the baseline assessment, 10 weekly appointments for the
CBT intervention, six exercise classes over eight weeks
for the exercise intervention, and two appointments for
each of three follow-up assessments) [21–23], stigma associated with both type 2 diabetes and depression [24],
participant beliefs about study participation (e.g. lack of
personal gain) [23, 24], diversification of communication
channels to reach potential participants [22], health literacy issues [22], and co-morbid illnesses that may impede
participation in studies [22, 23]. Each of these characteristics may have been relevant during study recruitment
and reflected in the effort necessary for successful study
enrollment.
These findings from the Program ACTIVE II recruitment experience demonstrate the considerable time,
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effort, and costs associated with recruiting participants
for this federally funded behavioral RCT. These expenditures far exceeded investigator expectations and demonstrated important lessons for investigators and sponsors
of future clinical trials. The costs incurred specifically
for recruitment activities were nearly $1400 per participant, with $836 of this amount attributable to the direct
costs required for recruitment of each enrolled participant, in line with direct recruitment costs reported by
other diabetes studies [25, 26]. While grant application
budgets tend to be focused on the costs associated with
interventions, recruitment costs are substantial and
should not be underestimated.
A second lesson was the amount of time needed to
meet our recruitment target. Our team anticipated that
we would complete recruitment activities within the first
24 months of the funding period. Instead, we required
4.5 years to achieve our goal. The extension of this
period was a function of the large number of people we
needed to contact to compete enrollment. The recruitment rates of this study (0.6%–1%) were significantly
lower than those observed in our previous pilot study
(8%) that used identical eligibility criteria [17], though
similar to the 1.3% recruitment rate experienced by another depression treatment trial [27]. In the Program
ACTIVE pilot work, Inbound recruitment approaches
were successfully used to achieve a smaller target sample
of 50 [17]. However, replication of those same methods
did not yield similar recruitment rates in the larger trial
at the same site (Table 4).
Continual reassessment of strategies and adaptations
to the recruitment plan were needed throughout the
recruitment period. The Outbound calling method
was particularly important for Program ACTIVE II as
people with depression may not seek mental health
treatment because of stigma [5, 28, 29] or take the
initiative to make the initial contact with a study [30].
This was especially relevant for our study considering
that we recruited people with current MDD, who are
relatively unlikely to initiate treatment for their
depression [31].
There are limitations to the data presented in this
paper. First, tracking of staff activities was not the primary goal of study data collection so some estimation
was required in our calculations. As a result, the total
effort of study staff may be underestimated for some
activities (we erred on the side of underestimation).

Table 3 Study limitations and potential biases
Study limitations

Potential biases

• Staff effort may be underestimated due to inconsistent
logging of time
• Reported costs have not been adjusted for inflation

• Stringent study exclusion criteria increased recruitment effort and costs
• Recruitment of people with MDD made recruitment more difficult
• Some staff members were not consistent in logging time spent on tasks,
resulting in some estimation of effort
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Table 4 Key points
• Recruitment to clinical trials is challenging
• Recruitment planning during the grant application phase needs to
reflect a realistic timeline and adequate budget
• Recruitment efforts for Program ACTIVE II cost an average of $1358 for
each of the 140 enrolled participants over four years
• Sufficient time, funds, and funder support as well as flexibility and
adaptation are necessary to meet recruitment goals

Additionally, figures reported are based on actual costs
over the period of recruitment (2012–2016) and have
not been adjusted for inflation. These numbers should
be adjusted by investigators for use in future research
budgets.
A critical element in the ultimate success of this trial
was the flexibility and continued support by the funding
agency as the investigators adapted to barriers to recruitment. The agency permitted additional time to complete
recruitment and demonstrated confidence in the investigators, who were the most knowledgeable about their
local barriers and needs. Had restrictions been placed on
study funding based original assumptions about recruitment rates and strategies, the investigators would not
have been able to demonstrate the effectiveness of the
interventions [32].

Conclusions
Recruitment remains the primary challenge to clinical
trials. Innovation and flexibility in response to changes
in the environment are critical to success. It is imperative that investigators plan conservatively for recruitment
effort and costs during the grant application stage. Despite significant recruitment challenges, investigators
should be mindful of meeting recruitment milestones or
risk continued funding. The percentage of studies being
funded has decreased substantially over the past 10 years
[32], so it is imperative that those trials that are funded
are successful in reaching their stated recruitment targets. However, not all conditions can be anticipated so
investigators must be allowed flexibility as well. Policies
that place study funding contingencies based upon
achieving short-term recruitment targets should balance
the risk of expenditures of failed studies against the loss
of scientific knowledge and intervention development
due to premature termination of studies requiring additional time and resources to meet recruitment goals.
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